Cargando…
MiRNA10b-directed nanotherapy effectively targets brain metastases from breast cancer
RNA interference represents one of the most appealing therapeutic modalities for cancer because of its potency, versatility, and modularity. Because the mechanism is catalytic and affects the expression of disease-causing antigens at the post-transcriptional level, only small amounts of therapeutic...
Autores principales: | Yoo, Byunghee, Ross, Alana, Pantazopoulos, Pamela, Medarova, Zdravka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7854676/ https://www.ncbi.nlm.nih.gov/pubmed/33531596 http://dx.doi.org/10.1038/s41598-021-82528-2 |
Ejemplares similares
-
Screening of potential miRNA therapeutics for the prevention of multi-drug resistance in cancer cells
por: Medarova, Zdravka, et al.
Publicado: (2020) -
Radiolabeling and PET–MRI microdosing of the experimental cancer therapeutic, MN-anti-miR10b, demonstrates delivery to metastatic lesions in a murine model of metastatic breast cancer
por: Le Fur, Mariane, et al.
Publicado: (2021) -
Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer
por: Yoo, Byunghee, et al.
Publicado: (2017) -
MicroRNA-710 regulates multiple pathways of carcinogenesis in murine metastatic breast cancer
por: Yoo, Byunghee, et al.
Publicado: (2019) -
RNAi-Mediated PD-L1 Inhibition for Pancreatic Cancer Immunotherapy
por: Yoo, Byunghee, et al.
Publicado: (2019)